GlassScriptPhysician profile
Ann M Henley
NPI 1982877809
$10,281.59
in general payments reported to CMS, 2019-2025
54 companies · $2,357 in 2025
The $2,357 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,628 · 2022: $1,688 · 2023: $2,016 · 2024: $2,593 · 2025: $2,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,965.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,715.45 | 2021-2025 | |
| Novo Nordisk INC | $1,132.57 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $1,109.36 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $839.42 | 2021-2025 | |
| Glaxosmithkline, LLC. | $676.45 | 2021-2025 | Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $555.95 | 2021-2025 | Mounjaro, Zepbound, Emgality |
| Amgen INC. | $382.34 | 2021-2024 | Otezla, Repatha |
| Axsome Therapeutics, INC. | $314.32 | 2023-2025 | Auvelity, Sunosi |
| Exact Sciences Corporation | $270.61 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $208.41 | 2023-2025 | Rexulti |
| Nestle Healthcare Nutrition INC. | $181.79 | 2021-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $174.99 | 2024-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $162.30 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $152.26 | 2021-2023 | |
| Dexcom, INC. | $149.09 | 2021-2025 | Dexcom G6 Transmitter |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.47 | 2021-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $140.03 | 2021-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Biohaven Pharmaceutical Holding Company LTD. | $134.87 | 2022 | |
| Supernus Pharmaceuticals, INC. | $131.71 | 2022 | Tlando, Xyosted |
| Jazz Pharmaceuticals INC. | $124.06 | 2022-2024 | |
| Aimmune Therapeutics, INC. | $117.13 | 2024-2025 | Zenpep |
| Biohaven Pharmaceuticals, INC. | $113.98 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $113.04 | 2022-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.86 | 2021-2025 | Jardiance |
| Idorsia Pharmaceuticals US INC | $91.22 | 2023-2024 | Quviviq |
| Lundbeck LLC | $80.60 | 2022-2025 | Rexulti |
| Astellas Pharma US INC | $80.26 | 2021-2023 | Veozah |
| Abbott Laboratories | $75.59 | 2021-2024 | Freestyle Libre 3 |
| Cardiovascular Systems INC. | $67.96 | 2021 | |
| Acella Pharmaceuticals, LLC | $65.38 | 2022-2025 | NP Thyroid 60 |
| Antares Pharma, INC. | $59.46 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Teva Pharmaceuticals USA, INC. | $59.06 | 2021 | |
| Alexion Pharmaceuticals, INC. | $56.94 | 2022-2024 | Strensiq |
| Takeda Pharmaceuticals U.S.A., INC. | $50.46 | 2021-2024 | Trintellix |
| Veryan Medical Incorporated | $48.69 | 2023 | Biomimics 3d Vascular Stent System |
| Cordis US Corp. | $39.84 | 2023 | S.M.A.R.T. |
| Alnylam Pharmaceuticals INC. | $36.76 | 2022-2023 | Onpattro |
| Optinose US, INC. | $31.34 | 2021 | |
| Ironshore Pharmaceuticals INC. | $28.90 | 2021-2022 | |
| Amarin Pharma, INC. | $25.50 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $22.87 | 2022 | |
| Globus Medical, INC. | $21.79 | 2025 | Senza |
| Biogen, INC. | $20.72 | 2021 | |
| Halozyme INC | $20.60 | 2023 | |
| Indivior INC. | $18.85 | 2024 | Sublocade |
| Pulmonx Corporation | $18.31 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Genentech USA, INC. | $17.74 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.46 | 2025 | Zoryve |
| Actelion Pharmaceuticals US, INC. | $15.28 | 2024 | Uptravi, Opsumit |
| Currax Pharmaceuticals LLC | $14.78 | 2022 | |
| Phathom Pharmaceuticals, INC. | $14.26 | 2024 | Voquezna |
| Krystal Biotech INC | $14.05 | 2024 | Vyjuvek |
| Ibsa Pharma INC. | $13.27 | 2023 | Tirosint, Licart |
| Janssen Pharmaceuticals, INC | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Henley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.